Metabolic disturbances in overlap syndrome (obstructive sleep apnoea + chronic obstructive pulmonary disease) and obstructive sleep apnoea (OSA) patients Source: Annual Congress 2010 - Clinical aspects of sleep apnoea Year: 2010
Comparison of plasma NT-proBNP level in overlap syndrome (obstructive sleep apnoea + chronic obstructive pulmonary disease) and obstructive sleep apnoea (OSA) Source: Annual Congress 2008 - Control of breathing and respiratory disorders during sleep Year: 2008
Prevalence and characteristics of patients with obstructive sleep apnea (OSA) and chronic obstructive pulmonary disease (COPD): “overlap syndrome (OS)” Source: Virtual Congress 2020 – Prevalence, characteristics and predictors of obstructive sleep apnoea Year: 2020
Chronic respiratory failure in patients with obstructive sleep apnea (OSA) Source: Eur Respir J 2005; 26: Suppl. 49, 569s Year: 2005
Prevalence of obstructive airway disease in patients with obstructive sleep apnea Source: Annual Congress 2012 - Physiology, heart failure and respiration in relation to OSA Year: 2012
Nocturnal desaturation without obstructive sleep apnea (OSA) in patients with mild/moderate chronic obstructive pulmonary disease (COPD): a link with systemic inflammation (SI)? Source: Annual Congress 2008 - Comorbidities in COPD Year: 2008
Prevalence of stroke in obstructive sleep apnoea (OSA) patients Source: Eur Respir J 2007; 30: Suppl. 51, 331s Year: 2007
Unrecognised obstructive sleep apnoea is common in severe peripheral arterial disease Source: Eur Respir J 2013; 41: 616-620 Year: 2013
The association of chronic obstructive pulmonary disease and sleep apnea syndrome (overlap syndrome) Source: Eur Respir J 2002; 20: Suppl. 38, 495s Year: 2002
Chronic obstructive pulmonary disease in patients with obstructive sleep apnea Source: Annual Congress 2009 - Control of breathing and respiratory disorders during sleep Year: 2009
Long term effects of PAP therapy on patients with obstructive sleep apnea (OSA) and chronic obstructive pulmonary disease (COPD) (overlap syndrome) Source: Sleep and Breathing Conference 2021 Year: 2021
Prevalence of co-morbidities and clinical features in patients with obstructive sleep apnea and chronic obstructive pulmonary disease. Source: International Congress 2018 – From continuous positive airway pressure (CPAP) and adherence to CPAP to asthma-COPD overlap syndrome (ACOS) Year: 2018
Correlations between cardiovascular diseases and diabetes in obstructive sleep apnoea (OSA) Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA I Year: 2012
Clinical phenotypes in patients with concomitant obstructive sleep apnea and chronic obstructive pulmonary disease Source: Annual Congress 2012 - Pharmacological and non-pharmacological management of COPD Year: 2012
The difference in obstructive sleep apnoea symptoms between patients with obstructive and inflammatory diseases Source: Eur Respir J 2005; 26: Suppl. 49, 65s Year: 2005
Cardiac arrythmias in chronic obstructive pulmonary disease and obstructive sleep apnoea syndrome Source: Eur Respir J 2006; 28: Suppl. 50, 645s Year: 2006
Prevalence of cardiorespiratory disease increase with increasing severity of obstructive sleep apnoea (OSA) Source: Eur Respir J 2002; 20: Suppl. 38, 322s Year: 2002
The effect of physical rehabilitation (PR) on the severity of symptoms of OSAS in patients with chronic obstructive pulmonary disease (COPD) and obstructive sleep apnoea syndrome (OSA) Source: International Congress 2016 – New insights into pulmonary rehabilitation for chronic lung diseases Year: 2016
Prevalence of very severe obstructive sleep apnea syndrome from symptomatic patients. Source: International Congress 2019 – Screening tools, prevalence and predictors of obstructive sleep apnoea Year: 2019
Masked hypertension and obstructive sleep apnea syndrome (OSAS) Source: Eur Respir J 2006; 28: Suppl. 50, 416s Year: 2006